{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:45:17Z","timestamp":1773668717812,"version":"3.50.1"},"reference-count":29,"publisher":"American Psychiatric Association Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PS"],"published-print":{"date-parts":[[2001,4]]},"DOI":"10.1176\/appi.ps.52.4.501","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:03:29Z","timestamp":1034359409000},"page":"501-507","source":"Crossref","is-referenced-by-count":40,"title":["Six-Month Outcomes for Patients Who Switched to Olanzapine Treatment"],"prefix":"10.1176","volume":"52","author":[{"given":"Douglas L.","family":"Noordsy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"O'Keefe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim T.","family":"Mueser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"230","reference":[{"key":"R5241161","doi-asserted-by":"crossref","unstructured":"Drake RE, Osher FC, Noordsy DL, et al: Diagnosis of alcohol use disorders in schizophrenia. Schizophrenia Bulletin 16:57-67, 1990","DOI":"10.1093\/schbul\/16.1.57"},{"key":"R5241162","doi-asserted-by":"crossref","unstructured":"Carey MP, Weinhardt LS, Carey KB: Prevalence of infection with HIV among the seriously mentally ill: review of the research and implications for practice. Professional Psychology Research and Practice 26:262- 268, 1995","DOI":"10.1037\/\/0735-7028.26.3.262"},{"key":"R5241165","doi-asserted-by":"crossref","unstructured":"Mueser KT, Bond GR, Drake RE, et al: Models of community care for severe mental illness: a review of research on case management. Schizophrenia Bulletin 24:37-74, 1998","DOI":"10.1093\/oxfordjournals.schbul.a033314"},{"key":"R5241166","doi-asserted-by":"crossref","unstructured":"Rosenheck R, Thomas J, Henderson W, et al: A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. New England Journal of Medicine 337:809-815, 1997","DOI":"10.1056\/NEJM199709183371202"},{"key":"R5241167","unstructured":"Essock S, Hargreaves WA, Covell N, et al: Clozapine's effectiveness for patients in state hospitals: results from a randomized trial. Psychopharmacology Bulletin 32:683- 697, 1996"},{"key":"R5241168","doi-asserted-by":"crossref","unstructured":"Schiller MJ, Shumway M, Hargreaves WA: Treatment costs and patient outcomes with use of risperidone in a public mental health setting. Psychiatric Services 50:228-232, 1999","DOI":"10.1176\/ps.50.2.228"},{"key":"R5241169","unstructured":"Noordsy DL, O'Keefe C: Effectiveness of combining atypical antipsychotics and psychosocial rehabilitation in a CMHC setting. Journal of Clinical Psychiatry 60(suppl 19):47-51, 1999"},{"key":"R52411610","doi-asserted-by":"crossref","unstructured":"Kopelowicz A, Liberman RP, Mintz J, et al: Comparison of efficacy of social skills training for deficit and nondeficit negative symptoms in schizophrenia. American Journal of Psychiatry 154:424-425, 1997","DOI":"10.1176\/ajp.154.3.424"},{"key":"R52411611","doi-asserted-by":"crossref","unstructured":"Mueser KT, Douglas MS, Bellack AS, et al: Assessment of enduring negative symptom subtypes in schizophrenia. Schizophrenia Bulletin 17:565-582, 1991","DOI":"10.1093\/schbul\/17.4.565"},{"key":"R52411612","doi-asserted-by":"crossref","unstructured":"Kane J, Honigfeld G, Singer J, et al: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison versus chlorpromazine\/benztropine. Archives of General Psychiatry 45:789-796, 1988","DOI":"10.1001\/archpsyc.1988.01800330013001"},{"key":"R52411613","doi-asserted-by":"crossref","unstructured":"Marder SR, Meibach RC: Risperidone in the treatment of schizophrenia. American Journal of Psychiatry 151:825-835, 1994","DOI":"10.1176\/ajp.151.6.825"},{"key":"R52411614","doi-asserted-by":"crossref","unstructured":"Tollefson GD, Beasley CM Jr, Tran P, et al: Olanzapine versus haloperidol in the treatment of schizophrenia and schizophreniform disorders: results of an international collaborative trial. American Journal of Psychiatry 154:457-465, 1997","DOI":"10.1176\/ajp.154.4.457"},{"key":"R52411615","doi-asserted-by":"crossref","unstructured":"Tollefson GD, Sanger TM: Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine. American Journal of Psychiatry 154:466-474, 1997","DOI":"10.1176\/ajp.154.4.466"},{"key":"R52411616","doi-asserted-by":"crossref","unstructured":"Rosenheck R, Tekell J, Peters J, et al: Does participation in psychosocial treatment augment the benefit of clozapine? Archives of General Psychiatry 55:618-625, 1998","DOI":"10.1001\/archpsyc.55.7.618"},{"key":"R52411618","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association Gold Award: Integrating dialectical behavioral therapy into a community mental health program. Psychiatric Services 49:1338- 1340, 1998","DOI":"10.1176\/ps.49.10.1338"},{"key":"R52411619","unstructured":"Noordsy DL, Torrey WC, Mead S, et al: Recovery-oriented pharmacology: redefining the goals of antipsychotic treatment. Journal of Clinical Psychiatry 61(suppl 3):22-29, 2000"},{"key":"R52411620","doi-asserted-by":"crossref","unstructured":"Stroul BA: Community support systems for persons with long-term mental illness: a conceptual framework. Psychosocial Rehabilitation Journal 12(3):9-26, 1989","DOI":"10.1037\/h0099536"},{"key":"R52411621","doi-asserted-by":"crossref","unstructured":"Drake RE: Brief history, current status, and future place of PACT. American Journal of Orthopsychiatry 68:172-175, 1998","DOI":"10.1037\/h0085086"},{"key":"R52411622","doi-asserted-by":"crossref","unstructured":"Bond GR, Becker DR, Drake RE, et al: An update on supported employment for people with severe mental illness. Psychiatric Services 48:335-346, 1997","DOI":"10.1176\/ps.48.3.335"},{"key":"R52411623","doi-asserted-by":"crossref","unstructured":"Mueser KT, Wallace CJ, Liberman RP: New developments in social skills training. Behavior Change 12:31-40, 1995","DOI":"10.1017\/S0813483900004368"},{"key":"R52411624","doi-asserted-by":"crossref","unstructured":"Mueser KT, Drake RE, Noordsy DL: Integrated mental health and substance abuse treatment for severe psychiatric disorders. Journal of Practical Psychiatry and Behavioral Health 4:129-139, 1998","DOI":"10.1097\/00131746-199805000-00001"},{"key":"R52411625","doi-asserted-by":"crossref","unstructured":"Drake RE, McHugo GJ, Clark RE, et al: A clinical trial of assertive community treatment for patients with co-occurring severe mental illness and substance use disorder. American Journal of Orthopsychiatry 68:201-215, 1998","DOI":"10.1037\/h0080330"},{"key":"R52411627","doi-asserted-by":"crossref","unstructured":"Andreasen NC: Negative symptoms in schizophrenia. Archives of General Psychiatry 39:784-788, 1982","DOI":"10.1001\/archpsyc.1982.04290070020005"},{"key":"R52411628","doi-asserted-by":"crossref","unstructured":"Drake RE, Wallach MA, Hoffman JS: Housing instability and homelessness among aftercare patients of an urban state hospital. Hospital and Community Psychiatry 40:46-51, 1989","DOI":"10.1176\/ps.40.1.46"},{"key":"R52411629","doi-asserted-by":"crossref","unstructured":"Drake RE, Wallach MA: Substance abuse among the chronic mentally ill. Hospital and Community Psychiatry 40:1041-1046, 1989","DOI":"10.1176\/ps.40.10.1041"},{"key":"R52411630","doi-asserted-by":"crossref","unstructured":"Drake RE, Osher FC, Wallach MA: Alcohol use and abuse in schizophrenia: a prospective community study. Journal of Nervous and Mental Disease 177:408-414, 1989","DOI":"10.1097\/00005053-198907000-00004"},{"key":"R52411631","doi-asserted-by":"crossref","unstructured":"McHugo GJ, Hargreaves WA, Drake RE, et al: Methodologic issues in assertive community treatment studies. American Journal of Orthopsychiatry 68:246-260, 1998","DOI":"10.1037\/h0080333"},{"key":"R52411633","doi-asserted-by":"crossref","unstructured":"Breier A, Hamilton SH: Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia. Biological Psychiatry 45:403-411, 1999","DOI":"10.1016\/S0006-3223(98)00291-1"},{"key":"R52411634","unstructured":"Weiden PJ, Aquila R, Emanuel M, et al: Long-term consideration after switching antipsychotics. Journal of Clinical Psychiatry 59(suppl 19):36-49, 1998"}],"container-title":["Psychiatric Services"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ps.52.4.501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T19:41:17Z","timestamp":1722368477000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ps.52.4.501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["10.1176\/appi.ps.52.4.501"],"URL":"https:\/\/doi.org\/10.1176\/appi.ps.52.4.501","relation":{},"ISSN":["1075-2730","1557-9700"],"issn-type":[{"value":"1075-2730","type":"print"},{"value":"1557-9700","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}